Bellicum Pharmaceuticals, located near the Houston Medical Center, is engineering high-performance cellular immunotherapies and unleashing their power against a wide range of cancers, impacting more patients than ever. Our cellular platform technology is designed to break through significant clinical barriers and activate the full power of cellular immunotherapies, with a focus on chimeric antigen receptor T-cell therapy (CAR-T).
View Top Employees from Bellicum Pharmaceuticals, Inc.Website | http://www.bellicum.com |
Ticker | BLCM |
Revenue | $58 million |
Funding | $394.2 million |
Employees | 35 (35 on RocketReach) |
Founded | 2003 |
Address | 3730 Kirby Dr Suite 1200, Houston, Texas 77030, US |
Phone | (832) 384-1100 |
Technologies |
JavaScript,
HTML,
Twitter
+33 more
(view full list)
|
Industry | Biotechnology Research, Pharmaceuticals, Biotechnology, Drug Discovery, Oncology, Healthcare, Science and Engineering, Vaccines, Health Diagnostics, Cell Therapy, Health Care, Bone Marrow Transplantation, Therapeutics |
Web Rank | 2 Million |
Keywords | Bellicum Pharmaceuticals, C-Type Lectin-Like Molecule 1 Hsc, Il-15 Car Nk Cells, Blcm Pharmaceuticals, Bellicum |
Competitors | Adaptimmune, Eureka Therapeutics, Inc, Immatics, Juno Therapeutics, Inc., Tessa Therapeutics Ltd |
SIC | SIC Code 283 Companies, SIC Code 87 Companies, SIC Code 28 Companies, SIC Code 2834 Companies |
NAICS | NAICS Code 541 Companies, NAICS Code 54138 Companies, NAICS Code 54 Companies, NAICS Code 5413 Companies |
Looking for a particular Bellicum Pharmaceuticals, Inc. employee's phone or email?
The Bellicum Pharmaceuticals, Inc. annual revenue was $58 million in 2024.
Rac Joseph Senesac is the Senior Vice President, Technical Operations of Bellicum Pharmaceuticals, Inc..
35 people are employed at Bellicum Pharmaceuticals, Inc..
Bellicum Pharmaceuticals, Inc. is based in Houston, Texas.
The NAICS codes for Bellicum Pharmaceuticals, Inc. are [541, 54138, 54, 5413].
The SIC codes for Bellicum Pharmaceuticals, Inc. are [283, 87, 28, 2834].